GLP-1 drugs like Ozempic, Wegovy, and Zepbound are changing medicine β but at what cost?
In this episode of The Exam Room Podcast, host Chuck Carroll sits down with Ben Urich, PharmD, PhD, to break down the real-world data behind the GLP-1 explosion.
You'll learn:
- How many people are actually using GLP-1 drugs - Why most users stop β and why that's starting to change - The true cost of GLP-1 medications to employers and health plans - Common and serious side effects to be aware of - Why GLP-1s are now being studied for Alzheimer's disease and addiction - What the future holds as more than 30 new drugs enter the pipeline
This is a must-watch conversation for anyone considering GLP-1 medications, currently using Ozempic or Wegovy, or wondering where modern weight-loss medicine is headed next.
π Support PCRM https://pcrm.org/examroommatch
